Durability of single-dose rVSV-ZEBOV vaccine responses: what do we know?

Durability of single-dose rVSV-ZEBOV vaccine responses: what do we know?

Introduction: The live-attenuated recombinant vesicular stomatitis virus vaccine expressing the glycoprotein (GP) of Zaire Ebola virus (rVSV-ZEBOV) has proven immunogenic in humans and effective in field studies. Yet long-term durability of vaccine responses is unknown. Areas covered: We survey the...

Full description

Bibliographic Details
Main Authors: Angela Huttner, Claire-Anne Siegrist
Format: Article
Language:English
Published: Taylor & Francis Group 2018-12-01
Series:Expert Review of Vaccines
Subjects:
ebola virus disease
ebola vaccine
rvsv-zebov vaccine
immune response
durability
persistence
seropositivity
Online Access:http://dx.doi.org/10.1080/14760584.2018.1546582

Internet

http://dx.doi.org/10.1080/14760584.2018.1546582

Similar Items